Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-01 Sale |
2023-03-03 7:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
10,988 | $45.65 | $501,602 | 104,115 (Direct) |
View |
2022-03-01 Sale |
2022-03-03 6:09 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
3,234 | $66.62 | $215,449 | 75,940 (Direct) |
View |
2021-10-14 Sale |
2021-10-18 6:55 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
358 | $81.14 | $29,048 | 40,148 (Direct) |
View |
2021-05-06 Sale |
2021-05-10 6:14 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
363 | $113.68 | $41,266 | 40,506 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 8:39 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
4,255 | $138.18 | $587,956 | 51,761 (Direct) |
View |
2020-10-14 Sale |
2020-10-16 7:18 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
262 | $88 | $23,056 | 34,699 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-03 Tax Withholding |
2025-03-04 8:02 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
1,348 | $42.92 | 140,665 (Direct) |
View |
2025-03-01 Option Award |
2025-03-04 8:02 pm |
N/A 2035-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
59,011 | $0 | 140,665 (Direct) |
View |
2024-03-01 Tax Withholding |
2024-03-05 8:17 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
470 | $53.69 | 114,402 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 8:17 pm |
N/A 2034-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
50,157 | $0 | 114,402 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 7:53 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
64,063 | $0 | 104,115 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 6:09 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
38,900 | $0 | 75,940 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 8:39 pm |
N/A 2031-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
21,136 | $0 | 51,761 (Direct) |
View |
2020-06-01 Tax Withholding |
2020-06-03 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
262 | $69.38 | 34,961 (Direct) |
View |
2020-05-06 Tax Withholding |
2020-05-08 8:10 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer |
248 | $66.26 | 34,979 (Direct) |
View |